Subscribe to RENAISSANCE - A multi-centre, non-interventional study of RElugolix as aNdrogen-deprivAtion therapy In patientS with advanced hormone-Sensitive prostate cANCEr | HMA-EMA Catalogues of real-world data sources and studies